Accentia Biopharmaceutical eyes exclusivity extension to find options

By Caroline Salls

Pittsburgh, July 6 - Accentia Biopharmaceuticals, Inc. has requested an extension to its exclusive plan-filing and vote-solicitation periods, according to a Monday filing with the U.S. Bankruptcy Court for the Middle District of Florida.

The company has asked the court to extend the exclusive filing period to Oct. 30 from July 8 and the solicitation period to Dec. 29 from Sept. 6.

Accentia said it needs the extension to allow it to thoroughly analyze its restructuring options and assess the approval process.

Accentia, a biopharmaceutical company based in Tampa, Fla., filed for bankruptcy on Nov. 10, 2008. Its Chapter 11 case number is 08-17795.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.